Hormone Receptor Positive / HER2-negative Breast Cancer
9 clinical trials · Condition
◉ Watch Hormone Receptor Positive / HER2-negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors (NCT05234606) | Silverback Therapeutics | 2022-03-01 |
| A Study of PRT2527 in Participants With Advanced Solid Tumors (NCT05159518) | Prelude Therapeutics | 2022-02-14 |
| ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma (NCT03394027) | National Cancer Institute (NCI) | 2018-01-17 |
Track Hormone Receptor Positive / HER2-negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.